Geneos Wealth Management’s Pacira BioSciences PCRX Stock Holding History

Geneos Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-363	Closed	-$8.68K	–	2988
2025 Q2	$8.68K	Sell	363 -21	-5%	-$529	﹤0.01%	2374
2025 Q1	$25.7K	Buy	384 +287	+296%	+$6.87K	﹤0.01%	2226
2024 Q4	$1.83K	Sell	97 -65	-40%	-$1.14K	﹤0.01%	2629
2024 Q3	$2.44K	Buy	+162	New	+$2.77K	﹤0.01%	2254
2023 Q4	–	Sell	-150	Closed	-$4.6K	–	2153
2023 Q3	$4.6K	Hold	150	–	–	﹤0.01%	1769
2023 Q2	$6.01K	Hold	150	–	–	﹤0.01%	1696
2023 Q1	$6.12K	Hold	150	–	–	﹤0.01%	1681
2022 Q4	$5.79K	Hold	150	–	–	﹤0.01%	1673
2022 Q3	$7K	Hold	150	–	–	﹤0.01%	1617
2022 Q2	$8K	Hold	150	–	–	﹤0.01%	2038
2022 Q1	$11K	Hold	150	–	–	﹤0.01%	2059
2021 Q4	$9K	Hold	150	–	–	﹤0.01%	2224
2021 Q3	$8K	Hold	150	–	–	﹤0.01%	2309
2021 Q2	$8K	Hold	150	–	–	﹤0.01%	2291
2021 Q1	$9K	Hold	150	–	–	﹤0.01%	2431
2020 Q4	$10K	Hold	150	–	–	﹤0.01%	2223
2020 Q3	$8K	Hold	150	–	–	﹤0.01%	2034
2020 Q2	$6K	Hold	150	–	–	﹤0.01%	2097
2020 Q1	$4K	Hold	150	–	–	﹤0.01%	2115
2019 Q4	$6K	Hold	150	–	–	﹤0.01%	2151
2019 Q3	$6K	Hold	150	–	–	﹤0.01%	2067
2019 Q2	$6K	Hold	150	–	–	﹤0.01%	2080
2019 Q1	$5K	Buy	+150	New	+$5.85K	﹤0.01%	2050
2017 Q1	–	Sell	-46	Closed	-$1K	–	2116
2016 Q4	$1K	Hold	46	–	–	﹤0.01%	1980
2016 Q3	$1K	Buy	+46	New	+$1.8K	﹤0.01%	1907

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geneos Wealth Management's PCRX Position: Q3 2025 in Review

Geneos Wealth Management sold out of Pacira BioSciences (PCRX) in Q3 2025, closing a stake of 363 shares — an estimated $8.68K sold.

Geneos Wealth Management first reported a position in PCRX in Q3 2016 and held it in 25 quarters. The position peaked at $25.7K in Q1 2025. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2025.

Geneos Wealth Management reported no remaining Pacira BioSciences position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 363 Pacira BioSciences shares in Q3 2025, an estimated $8.68K.
Geneos Wealth Management first reported a position in Pacira BioSciences in Q3 2016 and held it in 25 quarters.
Geneos Wealth Management's Pacira BioSciences position peaked at $25.7K in Q1 2025.
239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.